NCT00002765View on ClinicalTrials.gov

Immunotoxin in Treating Patients With Leukemia or Lymphoma

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

April 30, 1996

Conditions

LeukemiaLymphoma

Interventions

BIOLOGICAL

LMB-2 immunotoxin

Trial Locations (2)

20892

Laboratory of Molecular Biology, Bethesda

Medicine Branch, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH